Alberto Ferreira

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

J. Reginster, P. Sambrook, D. Reid, 2009, The Lancet.